Related Experiment Video
Updated: Jul 11, 2025

12:00
Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
Published on: April 8, 2009
10.4K
Exploring the key genomic variation in monkeypox virus during the 2022 outbreak.
1Institute of Clinical Virology, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Furong Road 678, Hefei, 230601, Anhui, China.
BMC Genomic Data
|November 16, 2023
Summary
Genomic variations in the B.1 lineage of monkeypox virus (MPXV) were analyzed. Key mutations, especially Class I variants, likely increased MPXV pathogenicity and transmissibility during the 2022 outbreak.
Area of Science:
- Virology
- Genomics
- Epidemiology
Background:
- The 2022 global monkeypox outbreak showed altered epidemiological characteristics.
- Monkeypox virus (MPXV) genomic variations are crucial for understanding pathogenicity and transmissibility.
- Investigating MPXV B.1 lineage variations is key for outbreak control.
Purpose of the Study:
- To evaluate key genomic variations in the MPXV B.1 lineage.
- To identify specific substitutions linked to the 2022 monkeypox outbreak.
- To understand the role of genomic variation in MPXV evolution.
Main Methods:
- Bioinformatics and phylogenetic analyses were employed.
- 979 MPXV strains were screened, with 212 analyzed for genomic substitutions.
- Reference sequences for 10 lineages were constructed to identify lineage-specific variants.
Main Results:
- Phylogenetic analysis identified 10 monophyletic branches.
- 49 substitutions specific to the B.1 lineage were found, including 23 non-synonymous.
- Class I variants among non-synonymous substitutions likely influenced MPXV characteristics in 2022.
Conclusions:
- This study elucidates MPXV B.1 lineage genomic variations linked to the 2022 outbreak.
- Key mutations, particularly Class I variants, explain changes in MPXV characteristics.
- Understanding these mutations aids in developing strategies for future monkeypox control.
Related Concept Videos
Viral Mutations
32.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K

